Lv4
418 积分 2025-02-07 加入
Qualitative structure-metabolism relationships in the hydrolysis of carbamates
1天前
已完结
ACP-196 Is a Second Generation Inhibitor of Bruton Tyrosine Kinase (BTK) with Enhanced Target Specificity
1个月前
已关闭
Atopic Dermatitis
1个月前
已完结
Molecular Characteristics of CTA056, a Novel Interleukin-2-Inducible T-Cell Kinase Inhibitor that Selectively Targets Malignant T Cells and Modulates Oncomirs
6个月前
已完结
Exploring the Role of Chemical Reactions in the Selectivity of Tyrosine Kinase Inhibitors
6个月前
已完结
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors
6个月前
已完结
Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in Vivo
6个月前
已完结
Discovery of DWP213388, a Potent ITK and BTK Selective Dual Inhibitor with Excellent Efficacy and Safety, for Treating Gvhd
6个月前
已完结
Property- and Structure-Guided Discovery of a Tetrahydroindazole Series of Interleukin-2 Inducible T-Cell Kinase Inhibitors
6个月前
已完结
Combined photocatalysis and solar distillation: Promoting synergistic effects for a more efficient VOC/SVOC rejection
1个月前
已采纳
ViGNet: A clinical data-supported deep learning approach for NSCLC immunotherapy response prediction in digital pathology
1个月前
已采纳
Enhanced coherent microwave-to-optics conversion based on second-order nonlinearity
1个月前
已采纳
Copper-Catalyzed Photocatalyst-Free Radical N -Glycosylation
5个月前
已采纳
Elemental Selection Rather than Entropy in Designing Low-Pt High-Entropy Intermetallics for Efficient Oxygen Reduction
5个月前
已采纳
Discovery of 3-benzyloxy-6-arylpyridazine derivatives as novel multi-target agents toward Parkinson's disease therapy
5个月前
已采纳
Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer
5个月前
已采纳
Discovery of 3-indolealkylamines as novel dual-target σ1R/H3R ligands with potent analgesia
5个月前
已采纳
Discovery of the first dual PD-L1/JAK inhibitor with enhanced in vivo antitumor immunity
5个月前
已采纳
Discovery of the first dual PD-L1/JAK inhibitor with enhanced in vivo antitumor immunity
5个月前
已采纳
皖公网安备34019202002308
